1. Home
  2. NRG vs RMD Comparison

NRG vs RMD Comparison

Compare NRG & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NRG Energy Inc.

NRG

NRG Energy Inc.

HOLD

Current Price

$169.63

Market Cap

28.9B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$229.36

Market Cap

33.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRG
RMD
Founded
1989
1989
Country
United States
United States
Employees
N/A
10600
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
33.6B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NRG
RMD
Price
$169.63
$229.36
Analyst Decision
Strong Buy
Buy
Analyst Count
13
10
Target Price
$202.23
$293.20
AVG Volume (30 Days)
2.1M
880.8K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
1.12%
1.05%
EPS Growth
N/A
N/A
EPS
4.01
N/A
Revenue
$30,713,000,000.00
N/A
Revenue This Year
$14.41
$10.64
Revenue Next Year
$3.32
$7.46
P/E Ratio
$41.01
$25.61
Revenue Growth
9.18
N/A
52 Week Low
$95.38
$202.00
52 Week High
$189.96
$293.81

Technical Indicators

Market Signals
Indicator
NRG
RMD
Relative Strength Index (RSI) 63.37 45.16
Support Level $158.65 $218.39
Resistance Level $172.52 $232.60
Average True Range (ATR) 5.76 5.43
MACD 2.60 1.66
Stochastic Oscillator 96.86 65.52

Price Performance

Historical Comparison
NRG
RMD

About NRG NRG Energy Inc.

NRG Energy is one of the largest retail energy providers in the US, with 6 million customers. Vivint Smart Home, which NRG acquired in 2023, has 2 million home-services customers. NRG also is one of the largest US independent power producers, with 13 gigawatts of coal, gas, and oil power generation capacity primarily in Texas. The LS Power asset acquisition adds 13 GW of gas-fired power plants mostly in the Eastern US. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: